Vaccines have significantly decreased or eradicated several deadly illnesses in the United States that formerly regularly killed or maimed newborns, adolescents, and adults. They function in conjunction with the body’s natural immunity to assist people in developing resistance to illness effectively. This reduces one’s risk of contracting particular illnesses and developing related consequences. Vaccines to combat sickness from SARS-CoV-2 are regarded as the most viable strategy for containing the COVID-19 pandemic (Al-Amer et al., 8). Vaccination is now giving a path out of this pandemic age. Without them, numerous scientists believe that natural population resilience would have been inadequate to restore the nation to pre-disaster levels, resulting in significant death rates. This opinion is echoed by several health organizations, most notably the WHO. Without immunizations, authoritarian restrictions may have been required for a plausible future. (Sallam & Malik, 13). Thankfully, some vaccinations received emergency permission and began rolling out in countries throughout the globe in early 2021. Since then, there have been remarkable results.
Challenges Facing the Covid-19 Vaccination
One of the most significant obstacles to immunization against Covid-19 is public opinion and hesitation in the United States (Khubchandani et al., 12). Vaccine reluctance is not a novel barrier to preventive measures; it was a significant issue throughout the influenza vaccination outbreak. Recently published research indicates that vaccine reluctance has been rising across various demographics, including healthcare personnel, in the past few years. Nowak et al. (4) noted that in the latest years, a popular change of general populace health vaccine resistance has grown in the United States, contributing to an upsurge in the proportion of the population in the US who oppose vaccination attempts. What contributes to this reticence are bad perceptions of vaccination. The COVID-19 epidemic wreaked havoc on society, profoundly impacting people’s feelings and well-being. It is impossible to quantify the epidemic’s effect on public opinion, much alone how individuals reacted to the spectacular occurrences that transpired throughout the outbreak. As a result, many have acquired unfavorable impressions of the Covid-19 vaccination due to how quickly it was developed and how effective it is, considering its short development period. Some feel that the vaccination may even create problems years after being administered. This, in turn, lowers the number of people ready to take the vaccines (Machingaidze et al., 8).
According to Fuller et al. (1), a significant obstacle to vaccination adoption among minority groups is a paucity of faith in authorities, medical corporations, and the vaccine production process itself. Minority groups in the United States continue to endure systematic racism and institutional disadvantages that date back to the imperial era. Adverse hospital encounters and past medical injustices contribute to increased distrust in the public health system. Despite substantiated vaccine reluctance among minority societies, administration guidelines have emphasized an individual’s obligation to vaccinate instead of tackling the causes of this reluctance and loss of trust and governance deficiencies that have played a role in the shortage of COVID-19 vaccine actress. This contributes to the myth that vaccination reluctance is caused by misinformation instead of complicated issues such as institutionalized racism and a lack of trust in public health and medical corporations. Most significantly, public health communication influences behavior by eliciting unpleasant or favorable emotions.
What has to be done then?
There is no questioning the vital nature of the Covid-19 vaccine. Numerous individuals are worried about the hazards associated with vaccinations. On the other hand, Vaccines have a long history of being a secure and beneficial method of disease prevention. Before it is licensed for use, it must undergo a rigorous testing procedure to ensure its safety. This entails conducting clinical trials” with many volunteers willing to test the vaccination. Researchers conduct these studies to see how effectively the vaccination functions and how many patients experience negative consequences. Therefore, everyone must draw on early lessons learned to modify and scale awareness efforts to aid authorities in communicating about the COVID-19 vaccination (DeRoo et al., 16). To strengthen the national capability and adjust to local circumstances, authorities must intensify these dialogues to address growing issues such as professional medical reluctance, susceptibility to misinformation, adolescent hesitancy, and attitudes about novel variations. Vaccine apprehensive individuals are uncertain about receiving the COVID vaccination and frequently have unique issues that may be resolved via customized messages offered by a trustworthy communicator.
Additionally, across areas and nations, individuals gravitate toward like-minded folks. Individuals’ vaccination beliefs are frequently congruent with the vaccine beliefs of the social structure to which they belong. As a result, customized vaccination messaging directed at certain demographics is critical. Often, medical providers deliver vaccinations, giving them a distinctive and subjective function in health engagement (Biswas et al., 4). They are accountable for responding to inquiries and, most importantly, providing reliable facts about the effectiveness of vaccinations. When stakeholders such as governments, health organizations, and the general public do not interact, they lose out on valuable prospects. A sizable segment of the population relies entirely on medical specialists for primary healthcare. This is an entity that cannot be ignored. Medical specialists have a critical function to perform, and they ought to be invited to participate in discussions around vaccination. While they may not be able to convince everyone to be vaccinated, they can help raise awareness regarding the critical need to protect everyone against Covid-19 and dispel misconceptions. Each patient immunized contributes to the goal of eradicating the illness.
I choose to concentrate on the audience in the post by connecting to their emotions. People behave in response to their emotions. To urge readers to examine the essay, I used an emotional appeal by first getting to know them and then giving experiences and individual experiences to get them interested in the issue. The article’s subject is Covid-19 vaccination, and its intended audience is the broader United States population. This target group was chosen since it is the most impacted by the issue. In the web post, I conveyed this by looking at the general aspects of the subject.
What have you learned about your topic as a result of your research?
From the study, I have learned that vaccination is the most critical measure we can do to safeguard our health. Nevertheless, if individuals stop receiving immunizations, infectious illnesses may soon resurface. While there has been some misinformation and misconception regarding Covid-19 vaccination, it is an essential component of public health.
How Did You Use The Writing/Revision Process to Improve Your Writing?
I utilized the revising process to get a new, critical perspective on the subject. Additionally, I utilized it to reassess the paper’s thesis, analyze the evidence, refine its aim, and restructure the presentation. Most importantly, I reflected on and re-envisioned the paper, considering the objectives and if I achieved them. I ensured that the concepts were articulated properly and were fully supported.
If you had more time and another draft, what is one thing you might change/improve in your web article?
If given another opportunity, I would concentrate my attention on a core target such as adults to construct more successful and complete research since reaching everyone at once is difficult. Understanding a certain target group is a critical first step toward doing productive research.
How Did You Use Research/Change Your Ideas About Research?
I approached research strategically, introducing new ideas, assisting in identifying issues and potential answers in novel ways, and developing new foundations to direct thought and action. Additionally, I utilized it to advance knowledge via evolutionary theory, thoughts, and ideas.
Al‐Amer, Rasmieh, et al. “COVID‐19 vaccination intention in the first year of the pandemic: A systematic review.” Journal of clinical nursing 31.1-2 (2022): 62-86.
Biswas, Nirbachita, et al. “The nature and extent of COVID-19 vaccination hesitancy in healthcare workers.” Journal of community health 46.6 (2021): 1244-1251.
DeRoo, Sarah Schaffer, Natalie J. Pudalov, and Linda Y. Fu. “Planning for a COVID-19 vaccination program.” Jama 323.24 (2020): 2458-2459.
Fuller, Harriett, et al. “Addressing Vaccine Hesitancy to Reduce Racial and Ethnic Disparities in COVID-19 Vaccination Uptake Across the UK and US.” Frontiers in public health 9 (2021).
Khubchandani, Jagdish, et al. “COVID-19 vaccination hesitancy in the United States: a rapid national assessment.” Journal of Community Health 46.2 (2021): 270-277.
Machingaidze, Shingai, and Charles Shey Wiysonge. “Understanding COVID-19 vaccine hesitancy.” Nature Medicine 27.8 (2021): 1338-1339.
Nowak, Glen J., Michael A. Cacciatore, and María E. Len-Ríos. “Understanding and increasing influenza vaccination acceptance: insights from a 2016 national survey of US adults.” International journal of environmental research and public health 15.4 (2018): 711.
Sallam, Malik. “COVID-19 vaccine hesitancy worldwide: a concise, systematic review of vaccine acceptance rates.” Vaccines 9.2 (2021): 160.